drugset
Drugs / 5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1
last change Mar 2010 re-read 3 minutes ago

5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1

Vaccine

Developed for
metastatic neoplasm
Investigated by
Human Genome Center, Institute of Medical Science, University of Tokyo · Kyushu University

Trials 1

today NCT00676949 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00676949 Nov 2007 → Mar 2010 metastatic neoplasm Kyushu University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00676949 ↗
Modality Vaccine “5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1” NCT00676949 ↗
Route Subcutaneous “4 weekly s.c. administration.” NCT00676949 ↗